About me
- Associate Professor of Clinical Medicine (Gastroenterology)
My Locations
Qualifications and experience
- American College of Gastroenterology, National
- American Gastroenterological Association, National
- Crohns and Colitis Foundation of America, National
- European Crohns and Colitis Organization, International
Treatments and Conditions
My research
Khan N, Sundararajan R, Patel M, Trivedi C, Yang YX Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study , Am J Gastroenterol: 2024
Khan N, Trivedi C, Shah Y, Patel M, Sundararajan R, Xie D, Yang YX Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort , J Clin Gastroenterol, 58(3): 2024,277-280
M C Dubinsky, M Gianfrancesco, G Gauthier, L Fallon, G R Lichtenstein, N H Khan, G Y Melmed, S Hanauer, T Ritter, G Bell, Y C Lee, N Kulisek, A Yndestad, D T Rubin Assessment of steroid use in patients with active ulcerative colitis who initiated a new Janus kinase inhibitor or tumour necrosis factor inhibitor using data from a United States claims database , Journal of Crohn's and Colitis: 2024
Sundararajan, Ramaswamy MBBS1; Patel, Manthankumar MBBS, MS1; Trivedi, Chinmay MD2; Khan, Nabeel 5-Year Outcomes of Adalimumab Use in Nationwide Cohort of Bio-Naïve Ulcerative Colitis Patients , The American Journal of Gastroenterology: 2023
Chiorean M, Ha C, Hur P, Sharma PP, Gruben D, Khan N Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database , Dig Dis Sci, 68(10): 2023,3985-399
Polson MK, Bahrain H, Ogden JF, Utkina K, Bucco RA, Khan N Financial burden associated with discordance to intravenous iron therapies in US patients with iron deficiency anemia , J Manag Care Spec Pharm, 29(7): 2023,818-824
Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease , Aliment Pharmacol Ther, 57(7): 2023,800-80
N Khan, N Mahmud, M Patel, R Sundararajan, W Reinisch Incidence of Long COVID and impact of medications on the risk of developing Long COVID in a nationwide cohort of Inflammatory Bowel Disease patients , Journal of Crohn's and Colitis: 2023
N Khan, M Patel, R Sundararajan Occurrence of moderate to severe anaemia and utilization and efficacy of intravenous iron therapies in a nationwide cohort of Inflammatory Bowel Disease patients , Journal of Crohn's and Colitis: 2023
Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W Incidence of Long COVID and impact of medications on the risk of developing Long COVID in a nationwide cohort of IBD patients , Clin Gastroenterol Hepatol: 2022